Title
EHR Interventions for "Beers Criteria" Prescribing: The Development and Impact of Computerized Clinical Decision Support Alerts ,Used
Sold by Ergodebooks, an authorized reseller.
Returns accepted within 30 days | support@ergodebooks.com
Shipping Information
- Free Standard Shipping — United States only
- Processing Time: 1–3 business days
- Estimated Delivery: 3–5 business days after dispatch
- Double-boxed, fully insured & discreetly packaged
- Tracking number sent via email once dispatched
- Orders over $250 require signature upon delivery. Taxes calculated at checkout.
Returns & Refund
Returns accepted within 30 days of delivery.
Damaged or Defective Item
Free return shipping + replacement or full refund
Wrong Item Received
Free return shipping + replacement or full refund
Change of Mind
Return shipping at customer's expense · 25% restocking fee applies
Payment Option
For over a decade, there has been a high prevalence of potentially inappropriate medication (PIM) use as defined by the "Beers criteria" in the outpatient elderly population. Using CPOE medication lists, the measured prevalence of PIMs as of April 1, 2006 was 23.3% (8,693/37,247) of patients at Intermountain Healthcare and 23.0% (5,528/24,004) at the Cleveland Clinic. Patient characteristics associated with PIMs were polypharmacy, female, and multiple primary care visits. A decision support system of geriatric precaution screening alerts for 86 PIMs was integrated into Intermountain Healthcare's CPOE system. A 9month prospective, randomized controlled trial of the system was conducted in 52 outpatient primary care and specialty clinics. Intervention clinics received the alerts, while control clinics received usual care. No significant difference in canceled PIM prescriptions was found between intervention clinics at 4.7% (187/3977) and control clinics at 4.8% (113/2364). None of the individual 86 PIM alerts showed significant differences. Positive physician feedback suggest the alerts have some clinical value.
⚠️ WARNING (California Proposition 65):
This product may contain chemicals known to the State of California to cause cancer, birth defects, or other reproductive harm.
For more information, please visit www.P65Warnings.ca.gov.